Scientists test Four-Drug cocktail in bid to halt advanced cancers
NCT ID NCT01087554
Summary
This early-stage trial aims to find the safest, most effective doses of four different drug combinations for patients with advanced cancer that hasn't responded to standard treatments. Researchers are testing vorinostat paired with one of three other drugs (sirolimus, everolimus, or temsirolimus) to see if these combinations can slow or stop cancer growth. The study will enroll up to 249 patients to determine the highest tolerable doses and monitor how the cancers respond.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.